Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Eurofins wins €48m contract for EU-wide genome sequencing

The European Centre for Disease Prevention and Control has awarded Eurofins a €48m whole-genome sequencing (WGS) contract for COVID-19 variant testing. The move demonstrates confidence that countries will be running high volumes of COVID-19 testing in the mid to long term.
April 22, 2021

Covid continues to boost Unilabs in 2021

Executive chairman Jos Lamers has told HBI that Covid sales continue to rise in Q1 and Q2 2021. They certainly boosted 2020 results at the international lab and imaging group owned by Apax Partners. Like rivals Synlab and Sonic, the business continues to roar away. 
April 15, 2021

Fleury acquires Sao Paulo orthopaedics group

Fleury Group, the second largest diagnostics group in Brazil, has signed an agreement to buy a two-thirds stake in orthopaedic and rehabilitation specialist Vita Ortopedia Servicos Especializados. This continues its march towards becoming an integrated platform.
April 15, 2021

Vithas puts weight behind new diagnostics division

Spain's second-largest hospital group Vithas has brought together its diagnostic arms into a new division called Vithas Diagnostics. It's headed by a new employee, who comes straight from Synlab.
April 8, 2021

Synlab to IPO in Frankfurt

Europe's largest lab group Synlab will list on the Frankfurt Stock Exchange in Q2 after releasing an intention to float document on Wednesday morning. The group says revenue will grow 17% this year to €3bn+ revenue and that COVID-19 revenue will only continue to grow.
April 7, 2021

EQT buys Partners’ stake in Cerba

EQT has agreed to buy Partners Group's stake in French lab group Cerba for a ball-park enterprise value of €4.5bn, making it a 12x multiple on the group's 2020 EBITDA.
March 31, 2021

Lifebrain for sale as EBITDA for lab groups near doubles

Italian lab group Lifebrain is the latest to take advantage of swollen revenues and profits in the lab sector with owner Investindustrial appointing Goldman Sachs and JP Morgan to explore a sale. Meanwhile, COVID-19 testing across Europe led to a near doubling of EBITDA for the largest players in the third quarter of 2020.
March 25, 2021

2021: A boom year for health care M&A

The M&A market has roared out of Covid in the first quarter according to the HBI Panel Discussion. Are multiples likely to drop and what is investor appetite?
March 25, 2021
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us